Estimation of minimum clinically important difference for pain in fibromyalgia
- PMID: 21312349
- DOI: 10.1002/acr.20449
Estimation of minimum clinically important difference for pain in fibromyalgia
Abstract
Objective: To estimate the minimum clinically important difference (MCID) for several pain measures obtained from the Brief Pain Inventory (BPI) for patients with fibromyalgia.
Methods: Data were pooled across 12-week treatment periods from 4 randomized, double-blind, placebo-controlled studies designed to evaluate the safety and efficacy of duloxetine for the treatment of fibromyalgia. Each study enrolled subjects with American College of Rheumatology--defined fibromyalgia who presented with moderate to severe pain. The MCIDs for the BPI average pain item score and the BPI severity score (the mean of the BPI pain scale values: right now, average, least, and worst) were estimated by anchoring against the Patient's Global Impressions of Improvement scale.
Results: The anchor-based MCIDs for the BPI average pain item and severity scores were 2.1 and 2.2 points, respectively. These MCIDs correspond to 32.3% and 34.2% reductions from baseline in scores.
Conclusion: In these analyses, the MCIDs for several pain measures obtained from the BPI were similar (∼2 points) and corresponded to a 30-35% improvement from baseline to end point. These findings may be beneficial for use in designing clinical trials in which the BPI is used to evaluate improvements in pain severity.
Trial registration: ClinicalTrials.gov NCT00190866 NCT00233025.
Copyright © 2011 by the American College of Rheumatology.
Similar articles
-
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.Arthritis Rheum. 2004 Sep;50(9):2974-84. doi: 10.1002/art.20485. Arthritis Rheum. 2004. PMID: 15457467 Clinical Trial.
-
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.Clin J Pain. 2009 Jul-Aug;25(6):461-8. doi: 10.1097/AJP.0b013e318197d4e4. Clin J Pain. 2009. PMID: 19542792
-
Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.Clin J Pain. 2012 Nov-Dec;28(9):775-81. doi: 10.1097/AJP.0b013e3182510295. Clin J Pain. 2012. PMID: 22971669 Clinical Trial.
-
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.Int J Clin Pract. 2007 Aug;61(8):1337-48. doi: 10.1111/j.1742-1241.2007.01444.x. Int J Clin Pract. 2007. PMID: 17627710 Review.
-
Fibromyalgia diagnosis and diagnostic criteria.Ann Med. 2011 Nov;43(7):495-502. doi: 10.3109/07853890.2011.595734. Epub 2011 Jul 19. Ann Med. 2011. PMID: 21770697 Review.
Cited by
-
Effects of Acupuncture Therapy on Drug-Resistant Fibromyalgia: An Exploratory Single-Arm Nonrandomized Trial.Med Acupunct. 2022 Jun 1;34(3):193-200. doi: 10.1089/acu.2022.0005. Epub 2022 Jun 16. Med Acupunct. 2022. PMID: 35832104 Free PMC article.
-
Analgesic efficacy of opioids in chronic pain: recent meta-analyses.Br J Pharmacol. 2015 Jan;172(2):324-33. doi: 10.1111/bph.12634. Epub 2014 Jul 1. Br J Pharmacol. 2015. PMID: 24640991 Free PMC article. Review.
-
Patients With Fibromyalgia Have Significant Autonomic Symptoms But Modest Autonomic Dysfunction.PM R. 2016 May;8(5):425-35. doi: 10.1016/j.pmrj.2015.08.008. Epub 2015 Aug 24. PM R. 2016. PMID: 26314231 Free PMC article.
-
Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study.J Pain. 2021 Dec;22(12):1709-1721. doi: 10.1016/j.jpain.2021.05.008. Epub 2021 Jun 27. J Pain. 2021. PMID: 34186177 Free PMC article.
-
Efficacy and acceptability of different blood flow restriction training interventions during the rehabilitation of military personnel with lower limb musculoskeletal injuries: protocol for a two-phase randomised controlled trial.BMJ Open. 2025 May 26;15(5):e096643. doi: 10.1136/bmjopen-2024-096643. BMJ Open. 2025. PMID: 40425246 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical